TITLE

Breast cancer care compared with clinical Guidelines: an observational study in France

AUTHOR(S)
Lebeau, Marie; Mathoulin-Pélissier, Simone; Bellera, Carine; Tunon-de-Lara, Christine; Daban, Alain; Lipinski, Francis; Jaubert, Dominique; Ingrand, Pierre; Migeot, Virginie
PUB. DATE
January 2011
SOURCE
BMC Public Health;2011, Vol. 11 Issue 1, p45
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background: Great variability in breast cancer (BC) treatment practices according to patient, tumour or organisation of care characteristics has been reported but the relation between these factors is not well known. In two French regions, we measured compliance with Clinical Practice Guidelines for non-metastatic BC care management and identified factors associated with non-compliance at clinical and organisational levels. Methods: Eligible patients had invasive unilateral BC without distant metastases and at least two contacts with one of the two regional healthcare systems (2003-2004) in the first year after diagnosis. Medical data were collected from patient medical records in all public and private hospitals (99 hospitals). The care process was defined by 20 criteria: clinical decisions for treatment and therapeutic procedures. Each criterion was classified according to level of compliance ("Compliant", "Justifiable" and "Not Compliant") and factors of non-compliance were identified (mixed effect logistic regression). Results: 926 women were included. Non-compliance with clinical decisions for treatment was associated with older patient age (OR 2.1; 95%CI: 1.3-3.6) and region (OR 3.0; 95%CI: 1.2-7.4). Non-compliance with clinical decisions for radiotherapy was associated with lymph node involvement or the presence of peritumoural vascular invasion (OR 1.5; 95%CI: 1.01-2.3) and non-compliance with overall treatment (clinical decisions for treatment + therapeutic procedures) was associated with the presence of positive lymph nodes (OR 2.0; 95%CI: 1.2-3.3), grade III versus grade I (OR 2.9; 95%CI: 1.4-6.2), and one region of care versus another (OR 3.5; 95%CI: 1.7-7.1). Finally, heterogeneity of compliance in overall treatment sequence was identified between local cancer units (p < 0.05). Conclusion: This study provides interesting insights into factors of non-compliance in non-metastatic BC management and could lead to quality care improvements.
ACCESSION #
59162572

 

Related Articles

  • Fighting cancer faster. SNH // Prevention;Jun2006, Vol. 58 Issue 6, p52 

    The article reports that radioactive pellets used to treat prostate cancer in men may replace traditional radiation treatment for women with early stage breast cancer. The method involves a single, hour-long procedure rather than daily treatments for 4 to 7 weeks that characterizes current...

  • More severe surgery reduces risk of breast cancer recurring.  // Australian Nursing Journal;Jul99, Vol. 7 Issue 1, p36 

    Provides information on a study which involved women with ductal carcinoma in situ, a cancer of the milk glands of the breast. Chance of the cancer reappearing after eight years among women whose surgeons removed a 10 millimeter margin around the tumor; Risk when the margin of additional tissue...

  • Retrospective evaluation of the treatment for breast cancer: how does the patient's personal experience of the treatment affect later adjustment to the illness? Alder, J.; Bitzer, J. // Archives of Women's Mental Health;2003, Vol. 6 Issue 2, p91 

    Summary.The aim of the present study was the evaluation of patients' treatment experience for breast cancer and its possible associations with the illness adjustment process. To examine perception and experience of treatment during the diagnostic and the inpatient phase, as well as during...

  • Black Women and Breast Cancer. Griffin, Regina // America;10/24/1998, Vol. 179 Issue 12, p20 

    Focuses on the rates at which Afro-American women develop and die from breast cancer in the United States. Help available for Afro-American women with breast cancer; Information on some Afro-American women cancer survivors; Implications for medical care in the state.

  • BREAST CANCER UPDATE. Bradshaw, Lauren // Glamour;Jul2006, Vol. 104 Issue 7, p78 

    The article presents various considerations before undergoing a breast cancer testing. Before undergo a breast cancer testing, a woman should consider if she has a history of breast cancer in any female family member; if her two first-degree relatives, mother or sister, have a breast cancer; if...

  • Effect of Prevailing Local Treatment Options of Breast Cancer on Survival Outside Controlled Clinical Trials: Experience of a Specialist Breast Unit in North India. Tewari, Mallika; Pradhan, S.; Kumar, M.; Shukla, H. S. // World Journal of Surgery;Oct2006, Vol. 30 Issue 10, p1794 

    Background: This study aimed at analyzing different treatments of breast cancer (BC) prevalent in the region, their effect on patients' survival, and discusses the most suitable method within available resources. Methods: The study was set up at a tertiary care hospital in north India. We...

  • The Direct Medical Costs of Breast Cancer in Iran: Analyzing the Patient's Level Data from a Cancer Specific Hospital in Isfahan. Davari, Majid; Yazdanpanah, Farkhondeh; Aslani, Abolfazl; Hosseini, Mohsen; Nazari, Ali Reza; Mokarian, Fairborz // International Journal of Preventive Medicine;Jul2013, Vol. 4 Issue 7, p748 

    Background: Breast cancer is one of the main causes of mortality and morbidity world wide. The estimation of the direct medical costs of breast cancer can help payers of the cost to understand the burden of breast cancer on their limited financial resources as well as the society. Methods: We...

  • Many quality measurements, but few quality measures assessing the quality of breast cancer care in women: A systematic review. Schachter, Howard M.; Mamaladze, Vasil; Lewin, Gabriela; Graham, Ian D.; Brouwers, Melissa; Sampson, Margaret; Morrison, Andra; Li Zhang; O'Blenis, Peter; Garritty, Chantelle // BMC Cancer;2006, Vol. 6, p291 

    Background: Breast cancer in women is increasingly frequent, and care is complex, onerous and expensive, all of which lend urgency to improvements in care. Quality measurement is essential to monitor effectiveness and to guide improvements in healthcare. Methods: Ten databases, including...

  • The Relationship Between Quality, Spending, and Outcomes Among Women With Breast Cancer. Hassett, Michael J.; Neville, Bridget A.; Weeks, Jane C. // JNCI: Journal of the National Cancer Institute;Oct2014, Vol. 106 Issue 10, p1 

    Background Substantial shortcomings in the quality of breast cancer (BC) care have been identified. While breast cancer is responsible for the largest share of cancer care spending, little is known about the value of care provided to US women with BC. Methods For women aged 65 to 70 years...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics